Fiscal year 2026 was the Company's first fiscal year operating under the LTC treasury strategy that commenced in
Fiscal Year 2026 Operational Highlights
- Closed a
$100.0 million private placement inJuly 2025 and deployed the gross proceeds into LTC, establishing LTC as the Company's primary treasury reserve asset and the largest public company holder of LTC; the Company held 832,716 LTC as ofJune 30, 2026 , representing over 1% of LTC currently mined; - Led a
$1.0 million strategic investment in LitVM, the first zero-knowledge Layer-2 platform bringing smart contract capability to the Litecoin network; - Shifted from accumulation to active capital markets operations in the second fiscal quarter, launching a covered call options program against LTC holdings and commencing repurchases of LITS common stock under a
$25.0 million share repurchase program approved inOctober 2025 ; - Initiated pre-clinical activities for voruciclib in non-oncology indications, retaining two drug candidates for potential out-licensing or sale opportunities and future sources of non-dilutive capital.
"Fiscal 2026 was the year we built the base for a Litecoin-centered treasury program,” said
Fiscal Year 2026 and Recent Financial Highlights
- Repurchased approximately 4.4 and 6.4 million LITS shares, or 12% and 17% of shares outstanding, from the commencement of the buyback program through
June 30, 2026 andSeptember 22, 2026 , respectively; halving the discount to net asset value (NAV) from the low 40% range into the low 20% range; - Premium proceeds generated from covered call program of approximately
$930,000 from program initiation throughSeptember 22, 2026 .
Cash and Liquidity
At
Litecoin Ecosystem Outlook
On
While the CLARITY Act did not advance in the
“Together, these efforts introduce a comprehensive, tailored securities offering regime intended to address long-standing barriers to responsible capital formation and innovation within domestic crypto asset markets, while preserving the investor protections at the core of federal securities laws,” said
Business Update and Strategic Focus
Looking ahead, management's primary objective is to grow LTC holdings per share through the active management of the Company's treasury.
We believe the opportunity underlying this strategy is significant. Institutional and corporate capital allocated to digital asset treasuries has grown rapidly over the past two years, yet that capital remains heavily concentrated in Bitcoin, leaving Litecoin as one of the longest-operating, most liquid and lowest-cost payment networks in digital assets, with a fixed, disclosed supply and a 15-year operating history; comparatively underrepresented relative to its scale, security and track record. Management believes that gap represents a durable opportunity: as regulatory clarity accelerates institutional adoption of LTC and as the network’s utility expands, demand for LTC should broaden beyond its traditional base as a payments asset. For
As the first
Beyond treasury management,
Following the Digital Asset Interpretation, and with a full fiscal year of operating record with our Litecoin-centered treasury program and no outstanding debt, management intends to expand direct engagement with banking partners, analysts and allocators. Alongside sustained education in the case for LTC as an institutional asset, a broader institutional understanding of LTC supports the value of the Company's own holdings. Management remains focused on bridging institutional capital to the Litecoin ecosystem. We believe
About Lite Strategy
Lite Strategy Inc. (Nasdaq LITS) is a San Diego-based digital asset treasury company that holds LTC as a primary reserve asset and pursues capital markets strategies designed to generate income from those holdings while retaining long-term exposure. Formerly MEI Pharma, Inc., the Company adopted its Litecoin treasury strategy in 2025 to diversify reserves, enhance capital efficiency and align with emerging financial technologies. Lite Strategy also retains a portfolio of pharmaceutical assets that it is managing for out-licensing or sale. More information is available at litestrategy.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding LTC and its potential performance, the Company’s Litecoin treasury strategy, the share repurchase program, out-licensing or sale of pharmaceutical assets and the sufficiency of the Company’s capital resources. These statements are subject to risks and uncertainties, including volatility in the price of LTC, the regulatory treatment of digital assets, the Company’s ability to maintain compliance with Nasdaq listing standards, potential dilution from outstanding warrants and options and the other risks described in the Company’s filings with the Securities and Exchange Commission. Actual results may differ materially. The Company undertakes no obligation to update any forward-looking statement except as required by law.
Contacts:
Investor Relations:
Alliance Advisors IR
Adele Carey
SVP, Investor Relations
investor@litestrategy.com
Public Relations:
Impact3
Casey Wilson
Director of Public Relations
media@litestrategy.com
Source: Lite Strategy, Inc.